Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Medexus Pharmaceuticals Inc. MEDXF

Set alert

Price alert · MEDXF

All alert types
3.56 USD -0.04 -1.19%

At close · Oct 30

3.53 Day range 3.53
1.80 52-week range 3.86
YTD
+68.58%
1 year
+78.74%
Open
3.53
Prev close
3.60
Mkt cap
111.78M
Vol
500
Avg vol
11.23K
EPS
-0.07
P/E
0.00
More statistics
Low
3.53
High
3.53

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MEDXF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -32.0×
FY 2017: -17.6×FY 2018: -10.1×FY 2019: -9.3×FY 2020: -6.1×FY 2021: -3.4×FY 2022: -16.7×FY 2023: 19.5×FY 2024: -120×FY 2025: 19.7×FY 2026: -32.0×
FY 2017 5y median -16.7× FY 2026
P/S 0.7×
FY 2017: 3.8×FY 2018: 3.5×FY 2019: 1.3×FY 2020: 0.5×FY 2021: 1.2×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.4×FY 2026: 0.7×
FY 2017 5y median 0.4× FY 2026
P/B 1.5×
FY 2017: 18.4×FY 2018: 8.9×FY 2019: 1.6×FY 2020: 1.7×FY 2021: 5.3×FY 2022: 2.7×FY 2023: 1.1×FY 2024: 0.8×FY 2025: 0.8×FY 2026: 1.5×
FY 2017 5y median 1.1× FY 2026
P/FCF 19.5×
FY 2017: -18.7×FY 2018: -7.6×FY 2019: -18.7×FY 2020: -16.4×FY 2021: -16.7×FY 2022: -5.5×FY 2023: -13.2×FY 2024: 1.4×FY 2025: 2.0×FY 2026: 19.5×
FY 2017 5y median 1.4× FY 2026
EV/EBITDA 7.0×
FY 2017: -7.4×FY 2018: -10.6×FY 2019: 37.6×FY 2020: 21.5×FY 2021: 18.1×FY 2022: 6.4×FY 2023: 5.6×FY 2024: 3.6×FY 2025: 3.3×FY 2026: 7.0×
FY 2017 5y median 5.6× FY 2026
EV/Sales 0.9×
FY 2017: 4.0×FY 2018: 3.6×FY 2019: 1.8×FY 2020: 0.9×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.9×
FY 2017 5y median 0.7× FY 2026
FCF Yield 5.1%
FY 2017: -5.3%FY 2018: -13.1%FY 2019: -5.4%FY 2020: -6.1%FY 2021: -6.0%FY 2022: -18.2%FY 2023: -7.6%FY 2024: 72.5%FY 2025: 49.7%FY 2026: 5.1%
FY 2017 5y median 5.1% FY 2026

Profitability

Gross Margin 54.8%
FY 2017: 55.2%FY 2018: 50.4%FY 2019: 66.5%FY 2020: 37.7%FY 2021: 52.7%FY 2022: 49.4%FY 2023: 55.5%FY 2024: 52.6%FY 2025: 52.2%FY 2026: 54.8%
FY 2017 5y median 52.6% FY 2026
Operating Margin 5.9%
FY 2017: -12.7%FY 2018: -36.6%FY 2019: -2.1%FY 2020: -10.4%FY 2021: -1.7%FY 2022: -16.2%FY 2023: 7.9%FY 2024: 9.5%FY 2025: 7.6%FY 2026: 5.9%
FY 2017 5y median 7.6% FY 2026
Net Margin -2.4%
FY 2017: -22.1%FY 2018: -34.8%FY 2019: -14.4%FY 2020: -7.9%FY 2021: -35.5%FY 2022: -3.8%FY 2023: 1.1%FY 2024: -0.2%FY 2025: 2.1%FY 2026: -2.4%
FY 2017 5y median -0.2% FY 2026
ROE -4.9%
FY 2017: -106.0%FY 2018: -88.8%FY 2019: -17.5%FY 2020: -25.5%FY 2021: -156.9%FY 2022: -16.2%FY 2023: 5.4%FY 2024: -0.7%FY 2025: 4.3%FY 2026: -4.9%
FY 2017 5y median -0.7% FY 2026
ROIC 6.1%
FY 2017: -21.4%FY 2018: -41.6%FY 2019: -0.9%FY 2020: -8.2%FY 2021: -1.0%FY 2022: -8.8%FY 2023: -1.7%FY 2024: -20.7%FY 2025: 7.4%FY 2026: 6.1%
FY 2017 5y median -1.7% FY 2026
ROA -1.6%
FY 2017: -23.7%FY 2018: -37.6%FY 2019: -5.7%FY 2020: -5.0%FY 2021: -19.0%FY 2022: -2.1%FY 2023: 0.8%FY 2024: -0.1%FY 2025: 1.3%FY 2026: -1.6%
FY 2017 5y median -0.1% FY 2026

Growth (YoY)

Revenue -8.3%
FY 2017: 64.4%FY 2018: 24.9%FY 2019: 336.9%FY 2020: 130.6%FY 2021: 2.0%FY 2022: -3.7%FY 2023: 40.9%FY 2024: 4.6%FY 2025: -4.2%FY 2026: -8.3%
FY 2017 FY 2026
Operating Income -29.0%
FY 2017: 81.3%FY 2018: -259.1%FY 2019: 75.1%FY 2020: -1051.7%FY 2021: 83.1%FY 2022: -801.3%FY 2023: 168.4%FY 2024: 27.2%FY 2025: -23.8%FY 2026: -29.0%
FY 2017 FY 2026
EPS (diluted) -185.5%
FY 2017: 24.3%FY 2018: -67.9%FY 2019: -2.1%FY 2020: 4.2%FY 2021: -304.3%FY 2022: 91.9%FY 2023: 140.0%FY 2024: -115.8%FY 2025: 962.1%FY 2026: -185.5%
FY 2017 FY 2026
Free Cash Flow -82.5%
FY 2017: 14.9%FY 2018: -178.7%FY 2019: 33.3%FY 2020: -4.0%FY 2021: -132.0%FY 2022: -55.6%FY 2023: 79.7%FY 2024: 1121.5%FY 2025: 15.5%FY 2026: -82.5%
FY 2017 FY 2026

Financial Health

Current Ratio 1.2×
FY 2017: 2.0×FY 2018: 3.5×FY 2019: 3.3×FY 2020: 0.8×FY 2021: 1.5×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 0.8×FY 2026: 1.2×
FY 2017 5y median 1.0× FY 2026
Quick Ratio 0.6×
FY 2017: 1.4×FY 2018: 2.4×FY 2019: 2.9×FY 2020: 0.4×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.6×
FY 2017 5y median 0.6× FY 2026
Debt / Equity 0.5×
FY 2017: 2.5×FY 2018: 1.1×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 2.5×FY 2022: 3.1×FY 2023: 3.1×FY 2024: 1.6×FY 2025: 0.7×FY 2026: 0.5×
FY 2017 5y median 1.6× FY 2026
Net Debt / EBITDA 1.2×
FY 2017: -0.2×FY 2018: -0.2×FY 2019: 9.9×FY 2020: 9.7×FY 2021: 3.9×FY 2022: 3.1×FY 2023: 4.0×FY 2024: 2.3×FY 2025: 0.8×FY 2026: 1.2×
FY 2017 5y median 2.3× FY 2026
Interest Coverage 1.1×
FY 2017: -1.0×FY 2018: -3.1×FY 2019: -0.2×FY 2020: -0.9×FY 2021: -0.1×FY 2022: -1.0×FY 2023: 0.6×FY 2024: 0.8×FY 2025: 1.0×FY 2026: 1.1×
FY 2017 5y median 0.8× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31